1. The UC San Diego AntiViral Research Center sponsors weeklypresentations by infectious disease clinicians, physicians andresearchers. The goal of these presentations is…

R&D for TB: Updates & Opportunities for the Private Sector Christian Lienhardt Senior Scientific Advisor, Stop TB Partnership WHO, Geneva GBC Conference on TB, TB/HIV…

Slide 1 Tuberculosis Vaccines: A strategic blueprint for the next decade Co-editors: Michael J. Brennan and Jelle Thole 1 Estimated number of cases Estimated number of deaths…

STOA-AVIESAN Workshop June 19th 2012; European Parliament; Bruxelles EMERGING INFECTIOUS DISEASES: A CONTINUOUS CHALLENGE FOR EUROPE EMERGING INFECTIOUS DISEASES: A CONTINUOUS…

Progress towards global targets for TB control Katherine Floyd Stop TB Department World Health Organization IUATLD conference Stop TB Symposium Cancun, 3 December 2009 To…

STOA-AVIESAN Workshop June 19th 2012; European Parliament; Bruxelles EMERGING INFECTIOUS DISEASES: A CONTINUOUS CHALLENGE FOR EUROPE EMERGING INFECTIOUS DISEASES: A CONTINUOUS…

R&D for TB: Updates & Opportunities for the Private Sector Christian Lienhardt Senior Scientific Advisor, Stop TB Partnership WHO, Geneva GBC Conference on TB, TB/HIV…

“HIV and TB – The Intersection of Two Epidemics” RADM Kenneth G. Castro, MD Acting Director, Division of HIV/AIDS Prevention National Center for HIV/AIDS, Viral Hepatitis,…